| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,726 | 9,108 | 4,324 | | Cost of Revenue | (2,682) | 12,007 | 1,034 | | | Gross Profit | 8,409 | (2,899) | 3,290 | | | Operating Expenses | | Research Development | 16,908 | 15,444 | 10,077 | | Selling General and Administrative | 13,540 | 12,771 | 9,374 | | Non Recurring | 3,605 |
-
|
-
| | Others | 4,481 | 1,954 | 1,520 | | | | Total Operating Expenses | 38,535 |
-
|
-
| | | | Operating Income or Loss | (30,126) | (33,067) | (17,681) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 883 | 1,100 | 653 | | Earnings Before Interest And Taxes | (28,971) | (31,967) | (17,029) | | Interest Expense | 97 | 134 | 172 | | Income Before Tax | (29,068) | (32,101) | (17,200) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | 272 | 631 |
-
| | | | Net Income From Continuing Ops | (29,068) | (31,471) | (17,200) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (29,068) | (31,471) | (17,200) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($29,068) | ($31,471) | ($17,200) |
|
1.48% Nasdaq 
Income Statement
